Detalhe da pesquisa
1.
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies.
Gene Ther
; 31(1-2): 1-11, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903929
2.
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
Oncologist
; 28(5): e242-e253, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961477
3.
Medicare Drug Price Negotiation in the United States: Implications and Unanswered Questions.
Value Health
; 26(3): 394-399, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36503034
4.
Designing a Value-Based Formulary for a Commercial Health Plan: A Simulated Case Study of Diabetes Medications.
Value Health
; 26(7): 1022-1031, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796479
5.
Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD-a large pragmatic trial.
Support Care Cancer
; 31(10): 598, 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770704
6.
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.
Oncology
; 100(2): 124-130, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844255
7.
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case Study.
Value Health
; 25(6): 1002-1009, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667773
8.
Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD.
BMC Health Serv Res
; 22(1): 432, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365139
9.
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme.
Diabetes Obes Metab
; 23(8): 1713-1721, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881797
10.
Are Drugs Priced in Accordance With Value? A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports.
Value Health
; 24(6): 789-794, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119076
11.
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
Diabetes Obes Metab
; 22(11): 2004-2012, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32729217
12.
Integrating Formal Technology Assessment into an Integrated Healthcare Delivery System: Smart Innovation.
Int J Technol Assess Health Care
; 36(1): 58-63, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228745
13.
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study.
Diabetes Obes Metab
; 21(9): 2123-2132, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31144445
14.
Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy.
Value Health
; 22(6): 661-668, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31198183
15.
Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.
BMC Med Res Methodol
; 19(1): 119, 2019 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31185918
16.
Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes.
Med Care
; 56(7): 583-588, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29762271
17.
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.
Diabetes Obes Metab
; 20(9): 2148-2158, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938887
18.
Has the Centers for Medicare & Medicaid Services Implicitly Adopted a Value Framework for Medicare Drug Price Negotiations?
Value Health
; 26(12): 1686-1688, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871678
19.
Price elasticities of pharmaceuticals in a value based-formulary setting.
Health Econ
; 27(11): 1788-1804, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028050
20.
Returns to scientific publications for pharmaceutical products in the United States.
Health Econ
; 27(2): 282-293, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28695605